BRUSSELS, Dec 7 (Reuters) - The head of the European
Medicines Agency (EMA) on Tuesday said that it could soon
approve the COVID-19 vaccine developed by U.S. biotech company
"The vaccine from Novavax could be authorised in the very
near future," Emer Cooke told EU health ministers during a
public session of a meeting in Brussels.
(Reporting by Francesco Guarascio
Editing by David Goodman)